Extra Virgin Olive Oil Polyphenols Promote Cholesterol Efflux and Improve HDL Functionality

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Berrougui, Hicham ^a,b   Ikhlef, Souad ^a   Khalil, Abdelouahed ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b SULTAN MOULAY SLIMANE UNIVERSITY   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; EXTRA VIRGIN OLIVE OIL; HIGH DENSITY LIPOPROTEIN; POLYPHENOL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL TRANSPORT; FEMALE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MALE; NORMAL HUMAN; OXIDATIVE STRESS;

EID: 84944272127     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/208062     Document Type: Article

References (53)

1. M. A. Ghaffari and T. Ghiasvand, "Kinetic study of low density lipoprotein oxidation by copper," Indian Journal of Clinical Biochemistry, vol. 25, no. 1, pp. 29-36, 2010
2. E. Favari, F. Zimetti,A. E. Bortnick et al., "ImpairedATP-binding cassette transporter A1-mediated sterol efflux fromoxidized LDL-loaded macrophages," FEBS Letters, vol. 579, no. 29, pp. 6537-6542, 2005
3. X. Mei and D. Atkinson, "Lipid-free apolipoprotein A-I structure: insights into HDL formation and atherosclerosis development," Archives of Medical Research, 2015
4. A. Rohatgi, "High-density lipoprotein functionmeasurement in human studies: focus on cholesterol efflux capacity," Progress in Cardiovascular Diseases, vol. 58, no. 1, pp. 32-40, 2015
5. S. W. Sakr, D. L. Williams, G. W. Stoudt, M. C. Phillips, and G. H. Rothblat, "Induction of cellular cholesterolefflux to lipid-free apolipoproteinA-I bycAMP," Biochimica et BiophysicaActa, vol. 1438, no. 1, pp. 85-98, 1999
6. J. C. Escolà-Gil, G. Llaverias, J. Julve, M. Jauhiainen, J. Méndez-González, and F. Blanco-Vaca, "The cholesterol content of western diets plays a major role in the paradoxical increase in highdensity lipoprotein cholesterol and upregulates themacrophage reverse cholesterol transport pathway," Arteriosclerosis,Thrombosis, and Vascular Biology, vol. 31, no. 11, pp. 2493-2499, 2011
7. N. Wang, D. L. Silver, C. Thiele, and A. R. Tall, "ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein," The Journal of Biological Chemistry, vol. 276, no. 26, pp. 23742-23747, 2001
8. F. C. McGillicuddy, M. L. de la Moya, C. C. Hinkle et al., "Inflammation impairs reverse cholesterol transport in vivo," Circulation, vol. 119, no. 8, pp. 1135-1145, 2009
9. H. Berrougui and A. Khalil, "Age-associated decrease of highdensity lipoprotein-mediated reverse cholesterol transport activity," Rejuvenation Research, vol. 12, no. 2, pp. 117-126, 2009
10. H. Berrougui, M. Isabelle, M. Cloutier, G. Grenier, and A. Khalil, "Age-related impairment of HDL-mediated cholesterol efflux," Journal of Lipid Research, vol. 48, no. 2, pp. 328-336, 2007
11. C. R. Sirtori, E. Gatti, E. Tremoli et al., "Olive oil, corn oil, and n-3 fatty acids differently affect lipids, lipoproteins, platelets, and Superoxide formation in type II hypercholesterolemia," American Journal of Clinical Nutrition, vol. 56,no. 1, pp. 113-122, 1992
12. J. S. Perona, J. Cañizares, E. Montero, J. M. Sánchez-Domínguez, A. Catalá, andV. Ruiz-Gutiérrez, "Virgin olive oil reduces blood pressure in hypertensive elderly subjects," Clinical Nutrition, vol. 23, no. 5, pp. 1113-1121, 2004
13. M.-I. Covas, K. Nyyssönen, H. E. Poulsen et al., "The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial," Annals of Internal Medicine, vol. 145, no. 5, pp. 333-341, 2006
14. A. Blanco-Molina, G. Castro,D. Martín-Escalante et al., "Effects of different dietary cholesterol concentrations on lipoprotein plasma concentrations and on cholesterol efflux from Fu5AH cells,"The American Journal of Clinical Nutrition, vol. 68, no. 5, pp. 1028-1033, 1998
15. M. A. Carluccio, M. Massaro, E. Scoditti, and R. De Caterina, "Vasculoprotective potential of olive oil components," Molecular Nutrition and Food Research, vol. 51, no. 10, pp. 1225-1234, 2007
16. H. Berrougui,M. Cloutier,M. Isabelle, andA. Khalil, "Phenolicextract fromargan oil (Argania spinosa L.) inhibits human lowdensity lipoprotein (LDL) oxidation and enhances cholesterol efflux from human THP-1 macrophages," Atherosclerosis, vol. 184, no. 2, pp. 389-396, 2006
17. M.-I. Covas, K. De La Torre, M. Farré-Albaladejo et al., "Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans," Free Radical Biology & Medicine, vol. 40, no. 4, pp. 608-616, 2006
18. M. Dell'Agli, R. Fagnani, N. Mitro et al., "Minor components of olive oilmodulate proatherogenic adhesionmolecules involved in endothelial activation," Journal of Agricultural and Food Chemistry, vol. 54, no. 9, pp. 3259-3264, 2006
19. B. Cortés, I. Núñez, M. Cofán et al., "Acute effects of highfat meals enriched with walnuts or olive oil on postprandial endothelial function," Journal of the American College of Cardiology, vol. 48, no. 8, pp. 1666-1671, 2006
20. F. M. Pirisi, P. Cabras, C. F. Cao, M. Migliorini, and M. Muggelli, "Phenolic compounds in virgin olive oil. 2. Reappraisal of the extraction, HPLC separation, and quantification procedures," Journal of Agricultural and Food Chemistry, vol. 48, no. 4, pp. 1191-1196, 2000
21. W. Sattler, D. Mohr, and R. Stocker, "Rapid isolation of lipoproteins and assessment of their peroxidation by highperformance liquid chromatography postcolumn chemiluminescence," Methods in Enzymology, vol. 233, pp. 469-489, 1994
22. A. Khalil, J.-P. Fortin, J.-G. LeHoux, and T. Fülöp, "Agerelated decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation," Journal of Lipid Research, vol. 41, no. 10, pp. 1552-1561, 2000
23. V. Marcil, E. Delvin, A. T. Sané, A. Tremblay, and E. Levy, "Oxidative stress influences cholesterol efflux in THP-1 macrophages: role of ATP-binding cassette A1 and nuclear factors," Cardiovascular Research, vol. 72, no. 3, pp. 473-482, 2006
24. A. Keys, A. Mienotti, M. J. Karvonen et al., "The diet and 15-year death rate in the seven countries study," American Journal of Epidemiology, vol. 124, no. 6, pp. 903-915, 1986
25. V. Konstantinidou, M.-I. Covas, D. Muñoz-Aguayo et al., "In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial," The FASEB Journal, vol. 24, no. 7, pp. 2546-2557, 2010
26. M.-I. Covas, "Olive oil and the cardiovascular system," Pharmacological Research, vol. 55, no. 3, pp. 175-186, 2007
27. R. Estruch, M. A. Martínez-González, D. Corella et al., "Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial," Annals of Internal Medicine, vol. 145, no. 1, pp. 1-11, 2006
28. T. Weinbrenner, M. Fitó, R. De La Torre et al., "Olive oils high in phenolic compoundsmodulate oxidative/antioxidative status in men," Journal of Nutrition, vol. 134, no. 9, pp. 2314-2321, 2004
29. R. Solà, A. E. La Ville, J. L. Richard et al., "Oleic acid rich diet protects against the oxidative modification of high density lipoprotein," Free Radical Biology & Medicine, vol. 22, no. 6, pp. 1037-1045, 1997
30. C. R. Sirtori, G. Franceschini, G. Gianfranceschi et al., "Activity profile of gemfibrozil on the major plasma lipoprotein parameters," European Journal of Epidemiology, vol. 8, supplement 1, pp. 120-124, 1992
31. F. Visioli, A. Poli, and C. Gall, "Antioxidant and other biological activities of phenols from olives and olive oil," Medicinal Research Reviews, vol. 22, no. 1, pp. 65-75, 2002
32. L. Calabresi, C. Banfi, C. R. Sirtori, and G. Franceschini, "Apolipoprotein A-II modulates HDL remodeling in plasma," Biochimica et Biophysica Acta-Lipids and Lipid Metabolism, vol. 1124, no. 2, pp. 195-198, 1992
33. J. S. Perona and V. Ruiz-Gutierrez, "Quantification of major lipid classes in human triacylglycerol-rich lipoproteins by highperformance liquid chromatography with evaporative lightscattering detection," Journal of Separation Science, vol. 27, no. 9, pp. 653-659, 2004
34. M. González-Santiago, J. Fonollá, and E. Lopez-Huertas, "Human absorption of a supplement containing purified hydroxytyrosol, a natural antioxidant from olive oil, and evidence for its transient association with low-density lipoproteins," Pharmacological Research, vol. 61, no. 4, pp. 364-370, 2010
35. D. J. Gordon and B. M. Rifkind, "High-density lipoprotein-the clinical implications of recent studies,"TheNew England Journal of Medicine, vol. 321, no. 19, pp. 1311-1316, 1989
36. J. A. Glomset, "The plasma lecithins: cholesterol acyltransferase reaction," The Journal of Lipid Research, vol. 9, no. 2, pp. 155-167, 1968
37. M. A. Kennedy, G. C. Barrera, K. Nakamura et al., "ABCG1 has a critical role in mediating cholesterol efflux toHDL and preventing cellular lipid accumulation," Cell Metabolism, vol. 1, no. 2, pp. 121-131, 2005
38. N. Wang, D. Lan, W. Chen, F. Matsuura, and A. R. Tall, "ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 26, pp. 9774-9779, 2004
39. Y. Ji, B. Jian, N. Wang et al., "Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux," The Journal of Biological Chemistry, vol. 272, no. 34, pp. 20982-20985, 1997
40. H. Uto-Kondo, M. Ayaori,M. Ogura et al., "Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages," Circulation Research, vol. 106, no. 4, pp. 779-787, 2010
41. M. Rosenblat, N. Volkova, R. Coleman, Y. Almagor, and M. Aviram, "Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux," Journal of Nutritional Biochemistry, vol. 19, no. 8, pp. 514-523, 2008
42. M. T. Montoya, A. Porres, S. Serrano et al., "Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity," American Journal of Clinical Nutrition, vol. 75, no. 3, pp. 484-491, 2002
43. O. Helal, H. Berrougui, S. Loued, and A. Khalil, "Extra-virgin olive oil consumption improves the capacity of HDL tomediate cholesterol efflux and increases ABCA1 and ABCG1 expression in human macrophages," British Journal of Nutrition, vol. 109, no. 10, pp. 1844-1855, 2013
44. M. N. Franco, T. Galeano-Díaz, O. López et al., "Phenolic compounds and antioxidant capacity of virgin olive oil," Food Chemistry, vol. 163, pp. 289-298, 2014
45. S. Cicerale, L. J. Lucas, and R. S. J. Keast, "Antimicrobial, antioxidant and anti-inflammatory phenolic activities in extra virgin olive oil," Current Opinion in Biotechnology, vol. 23, no. 2, pp. 129-135, 2012
46. M. I. Covas, M. Fitó, R. M. Lamuela-Raventós, N. Sebastiá, C. DeLaTorre-Boronat, and J. Marrugat, "Virginoliveoil phenolic compounds: binding to human low density lipoprotein (LDL) and effect on LDL oxidation," International Journal of Clinical Pharmacology Research, vol. 20, no. 3-4, pp. 49-54, 2000
47. R. M. Lamucla-Raventós,M.-I. Covas, M. Fitó, J. Marrugat, and M. C. de la Torre-Boronat, "Detection of dietary antioxidant phenolic compounds in human LDL," Clinical Chemistry, vol. 45, no. 10, pp. 1870-1872, 1999
48. Á. Hernáez, S. Fernández-Castillejo, M. Farràs et al., "Olive oil polyphenols enhance high-density lipoprotein function in humans: a randomized controlled trial,"Arteriosclerosis,Thrombosis, and Vascular Biology, vol. 34, no. 9, pp. 2115-2119, 2014
49. F. Pazzucconi, L. Mannucci, L. Mussoni et al., "Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia," European Journal of Clinical Pharmacology, vol. 43, no. 3, pp. 219-223, 1992
50. H. Y. Chung, M. Cesari, S. Anton et al., "Molecular inflammation: underpinnings of aging and age-related diseases," Ageing Research Reviews, vol. 8, no. 1, pp. 18-30, 2009
51. K. Trudel, D. Sinnett, R. W. James et al., "Iron-ascorbic acidinduced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats," Journal ofCellular Biochemistry, vol. 96,no. 2, pp. 404-411,2005
52. M. Sevov, L. Elfineh, and L. B. Cavelier, "Resveratrol regulates the expression of LXR-alpha in humanmacrophages," Biochemical and Biophysical Research Communications, vol. 348, no. 3, pp. 1047-1054, 2006
53. H. Berrougui, G. Grenier, S. Loued, G. Drouin, and A. Khalil, "A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux," Atherosclerosis, vol. 207, no. 2, pp. 420-427, 2009.